Literature DB >> 15048146

Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.

A Verma, S Williams, S Trifilio, T Zembower, J Mehta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15048146     DOI： 10.1038/sj.bmt.1704485

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

1.  In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.

Authors:  Marta Torres-Narbona; Jesús Guinea; José Martínez-Alarcón; Teresa Peláez; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

2.  Impact of zygomycosis on microbiology workload: a survey study in Spain.

Authors:  Marta Torres-Narbona; Jesús Guinea; José Martínez-Alarcón; Patricia Muñoz; Ignacio Gadea; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

Review 3.  Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.

Authors:  Maddalena Chermetz; Margherita Gobbo; Katia Rupel; Giulia Ottaviani; Giancarlo Tirelli; Rossana Bussani; Roberto Luzzati; Roberto Di Lenarda; Matteo Biasotto
Journal:  Mycopathologia       Date:  2016-06-27       Impact factor: 2.574

4.  PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue.

Authors:  R Bialek; F Konrad; J Kern; C Aepinus; L Cecenas; G M Gonzalez; G Just-Nübling; B Willinger; E Presterl; C Lass-Flörl; V Rickerts
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 5.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

6.  Amphotericin B May Decrease the Serum Level of Voriconazole: A Case Report and Brief Review of Literature.

Authors:  Zhen Hu; Huaying Zhou
Journal:  Infect Drug Resist       Date:  2022-09-12       Impact factor: 4.177
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.